Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Nova Leap Health Corp V.NLH

Alternate Symbol(s):  NVLPF

Nova Leap Health Corp. is a Canada-based acquisitive home health care services company operating in the United States (U.S.) and Canada. The Company, through its subsidiaries, provides various services to clients and families, including dementia care, companionship, personal care, respite care, cooking and meal preparation, light housekeeping, activities of daily living (ADL), transportation... see more

TSXV:NLH - Post Discussion

Nova Leap Health Corp > Convincing indications for Q1 (should presents next week)
View:
Post by BetulaKapital on Apr 28, 2022 9:37am

Convincing indications for Q1 (should presents next week)

Very convincing words from Amedisys and Encompass Q1 reports from their home care business  yesterday. Solid and increased earnings, this despite a weak start in early January due to Omicron. Hospitals and hospices have a harder time tying up labor compared to home care, which I have shown with static before.
 
Add that Nova Leap Health has 3 major acquisitions from exactly at the end of Q4 that will be included in full in Q1 (will probably be released 5 May on historical dates):

December 6: South Carolina - Annual Revenue (USD) $1,788 million and EBITDA of $96,000 (2021)
 
December 13: Kentucky and Indiana - Annual Revenue (USD) $4.1 million and EBITDA of $825,000 (2021)
 
December 17: Texas - Annual Revenue (USD) $3,371 million and EBITDA of $325,000
 
Also remember that these results come from a full year imprinted with Covid-19.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities